venlafaxine hydrochloride

Generic: venlafaxine hydrochloride

Labeler: nivagen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine hydrochloride
Labeler nivagen pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Nivagen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 75834-218
Product ID 75834-218_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211323
Listing Expiration 2026-12-31
Marketing Start 2019-09-06

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 75834218
Hyphenated Format 75834-218

Supplemental Identifiers

RxCUI
808744 808748 808753
UPC
0375834217000 0375834219004
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine hydrochloride (source: ndc)
Application Number ANDA211323 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-00)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-90)
source: ndc

Packages (3)

75834-218-00 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-00) 75834-218-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-30) 75834-218-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-90)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

VENLAFAXINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "bb5cc2c4-6d14-42aa-a9af-dc29bae4f238", "openfda": {"upc": ["0375834217000", "0375834219004"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748", "808753"], "spl_set_id": ["45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-00)", "package_ndc": "75834-218-00", "marketing_start_date": "20190906"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-30)", "package_ndc": "75834-218-30", "marketing_start_date": "20190906"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (75834-218-90)", "package_ndc": "75834-218-90", "marketing_start_date": "20190906"}], "brand_name": "VENLAFAXINE HYDROCHLORIDE", "product_id": "75834-218_bb5cc2c4-6d14-42aa-a9af-dc29bae4f238", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "75834-218", "generic_name": "VENLAFAXINE HYDROCHLORIDE", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VENLAFAXINE HYDROCHLORIDE", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA211323", "marketing_category": "ANDA", "marketing_start_date": "20190906", "listing_expiration_date": "20261231"}